PsyRX CNS Bio-Tech Ltd (TLV:PSRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 95.30
+0.30 (0.32%)
At close: Feb 4, 2026
PsyRX CNS Bio-Tech Market Cap
PsyRX CNS Bio-Tech has a market cap or net worth of 9.7 million as of February 5, 2026. Its market cap has increased by 78.28% in one year.
Market Cap
9.70M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
95.30
Market Cap Chart
Since July 25, 2021, PsyRX CNS Bio-Tech's market cap has decreased from 329.34M to 9.70M, a decrease of -97.05%. That is a compound annual growth rate of -54.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 9.70M | -0.84% |
| Dec 31, 2025 | 9.79M | 100.78% |
| Dec 31, 2024 | 4.87M | -44.97% |
| Dec 31, 2023 | 8.86M | -64.09% |
| Dec 29, 2022 | 24.66M | -59.42% |
| Dec 30, 2021 | 60.77M | -81.55% |
| Jul 25, 2021 | 329.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Upsellon Brands Holdings | 15.68M |
| Automax Motors | 11.20M |
| Rotem Energy Mineral (REM) - Limited Partnership | 10.99M |
| Millennium Food Tech Limited Partnership | 10.62M |
| Abou Family Residence | 9.63M |
| Sonovia | 9.48M |
| Shure-Tech Investments - Limited Partnership | 9.06M |
| Petrotx - Limited Partnership | 8.67M |